EvoNext Holdings SA (ELVAF)
OTCMKTS · Delayed Price · Currency is USD
0.9000
0.00 (0.00%)
At close: Jun 3, 2025
EvoNext Holdings Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
78
Market Cap
9.87M USD
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 9.44M | -6.10M | -39.27% |
| Dec 31, 2022 | 15.54M | 5.66M | 57.32% |
| Dec 31, 2021 | 9.88M | 2.34M | 30.99% |
| Dec 31, 2020 | 7.54M | -4.06M | -34.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
EvoNext Holdings News
- 2 years ago - Evolva Holding SA (ELVAF) Q2 2023 Earnings Call Transcript - Seeking Alpha
- 2 years ago - Evolva Holding SA (ELVAF) Q4 2022 Earnings Call Transcript - Seeking Alpha
- 3 years ago - Evolva Holding SA (ELVAF) Half Year 2022 Earnings Call Transcript - Seeking Alpha